Our findings show that antiestrogen resistant breast cancer cells express higher levels of MYC protein compared with sensitive cells, and elevated MYC levels correlate with increased sensitivity to deprivation of glutamine and glucose. The gene discussed is MYC; the disease is breast carcinoma.